Searchable abstracts of presentations at key conferences in endocrinology

ea0008p80 | Reproduction | SFE2004

Arterial viscoelastic properties and blood pressure in pregnant women with polycystic ovary syndrome

Hu S , Seifalian AM , Hardiman P

Objective: We previously reported that the reduced arterial elasticity in polycystic ovary syndrome (PCOS) women is present in the first trimester of pregnancy. Women with reduced arterial elasticity are more likely to develop pre eclampsia, which association with PCOS is still unproven. This study was designed to compare blood pressure (BP) and arterial elasticity in pregnant PCOS women and controls in second trimester.Methods: The subjects were 15 preg...

ea0026p263 | Pituitary | ECE2011

Octreotide pharmacokinetics and biochemical control of acromegaly using a subcutaneous octreotide hydrogel implant

Chieffo C , Ryan M , Bai S , Hu X , Decker S , Quandt H , Frohman L , Gadelha M

Two randomized open-label, phase II studies evaluated an octreotide hydrogel implant to suppress serum GH and IGF1 levels in adult acromegaly patients. Implants were inserted subcutaneously in the upper arm for 6 months. Patients in study 1 received 1 (n=5) or 2 (n=6) 52-mg octreotide (60 mg octreotide acetate) hydrated implants; patients in study 2 received a hydrated (H) or nonhydrated (NH) 84-mg octreotide acetate implant (n=34, 1 excluded from efficacy...